ARCHIVES

In Setback For Generics, Court Overturns FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Greenwald Lists Plans For $40 Million Raise In Prevention & Control

December 3, 1993

Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin

January 16, 2009

NCI, Canary Foundation Fund Biomarker Studies In Lung Cancer Of Never-Smokers

May 8, 2009

Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure

September 16, 2011